Across TCGA pan-cancer cohorts, BTBD19 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated BTBD19 data layer compared with 29 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher BTBD19 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated BTBD19 expression acts as an unfavorable survival marker.

LSCC are the cancer types where BTBD19 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Median	All	0.906	1.000	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: BTBD19 tumor-vs-normal RNA expression · all BTBD19 data types